Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(3), P. 555 - 555
Published: March 15, 2022
The
heme
oxygenase
(HO)
enzyme
system
catabolizes
to
carbon
monoxide
(CO),
ferrous
iron,
and
biliverdin-IXα
(BV),
which
is
reduced
bilirubin-IXα
(BR)
by
biliverdin
reductase
(BVR).
HO
activity
represented
two
distinct
isozymes,
the
inducible
form,
HO-1,
a
constitutive
HO-2,
encoded
genes
(HMOX1,
HMOX2,
respectively).
HO-1
responds
transcriptional
activation
in
response
wide
variety
of
chemical
physical
stimuli,
including
its
natural
substrate
heme,
oxidants,
phytochemical
antioxidants.
expression
regulated
NF-E2-related
factor-2
counter-regulated
Bach-1,
heme-sensitive
manner.
Additionally,
HMOX1
promoter
polymorphisms
have
been
associated
with
human
disease.
induction
can
confer
protection
inflammatory
conditions
through
removal
pro-oxidant
potential
catalyst
lipid
peroxidation,
whereas
iron
released
from
may
trigger
ferritin
synthesis
or
ferroptosis.
production
heme-derived
reaction
products
(i.e.,
BV,
BR)
contribute
HO-dependent
cytoprotection
via
antioxidant
immunomodulatory
effects.
BVR
BR
newly
recognized
roles
regulation.
CO
alter
mitochondrial
function
leading
modulation
downstream
signaling
pathways
that
culminate
anti-apoptotic,
anti-inflammatory,
anti-proliferative
This
review
will
present
evidence
for
beneficial
effects
diseases,
cardiovascular
disease
(CVD),
metabolic
conditions,
diabetes
obesity,
as
well
acute
chronic
diseases
liver,
kidney,
lung.
Strategies
targeting
pathway,
genetic
expression,
application
BR,
gas,
donor
compounds
show
therapeutic
organ
ischemia/reperfusion
injury.
Evidence
studies
indicate
represent
biomarker
oxidative
stress
various
clinical
while
increases
serum
levels
correlated
inversely
risk
CVD
Ongoing
trials
investigate
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(12), P. 2377 - 2377
Published: Nov. 30, 2022
Cerebral
ischemic
stroke
is
characterized
by
acute
ischemia
in
a
certain
part
of
the
brain,
which
leads
to
brain
cells
necrosis,
apoptosis,
ferroptosis,
pyroptosis,
etc.
At
present,
there
are
limited
effective
clinical
treatments
for
cerebral
stroke,
and
recovery
blood
circulation
will
lead
ischemia-reperfusion
injury
(CIRI).
involves
many
pathological
processes
such
as
oxidative
stress,
inflammation,
mitochondrial
dysfunction.
Nuclear
factor
erythroid
2-related
2
(Nrf2),
one
most
critical
antioxidant
transcription
factors
cells,
can
coordinate
various
cytoprotective
inhibit
stress.
Targeting
Nrf2
considered
potential
strategy
prevent
treat
injury.
During
ischemia,
participates
signaling
pathways
Keap1,
PI3K/AKT,
MAPK,
NF-κB,
HO-1,
then
alleviates
or
CIRI
inhibiting
anti-inflammation,
maintaining
homeostasis,
protecting
blood–brain
barrier,
ferroptosis.
In
this
review,
we
have
discussed
structure
Nrf2,
mechanisms
related
research
on
treatment
through
pathway
recent
years,
expounded
important
role
future
stroke.
Antioxidants,
Journal Year:
2021,
Volume and Issue:
10(12), P. 1859 - 1859
Published: Nov. 23, 2021
Oxidative
stress
is
a
pathological
condition
occurring
due
to
an
imbalance
between
the
oxidants
and
antioxidant
defense
systems
in
body.
Nuclear
factor
E2-related
2
(NRF2),
encoded
by
gene
NFE2L2,
master
regulator
of
phase
II
enzymes
that
protect
against
oxidative
inflammation.
NRF2/ARE
signaling
has
been
considered
as
promising
target
stress-mediated
diseases
like
diabetes,
fibrosis,
neurotoxicity,
cancer.
The
consumption
dietary
phytochemicals
acts
effective
modulator
various
acute
chronic
diseases.
In
present
review,
we
discussed
role
NRF2
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
cancer,
atherosclerosis.
Additionally,
curcumin,
quercetin,
resveratrol,
epigallocatechin
gallate,
apigenin,
sulforaphane,
ursolic
acid
have
effectively
modified
prevented
both
vitro
vivo
models.
Based
on
literature,
it
clear
can
prevent
(1)
blocking
stress-inhibiting
inflammatory
mediators
through
inhibiting
Keap1
or
activating
Nrf2
expression
its
downstream
targets
nucleus,
including
HO-1,
SOD,
CAT;
(2)
regulating
kinases
GSK3beta,
PI3/AKT,
MAPK;
(3)
modifying
epigenetic
modulation,
such
methylation,
at
promoter
region;
however,
further
investigation
into
other
upstream
molecules
effect
them
still
need
be
investigated
near
future.
Molecules,
Journal Year:
2021,
Volume and Issue:
26(7), P. 1844 - 1844
Published: March 25, 2021
Superoxide
dismutases
(SODs)
are
metalloenzymes
that
play
a
major
role
in
antioxidant
defense
against
oxidative
stress
the
body.
SOD
supplementation
may
therefore
trigger
endogenous
machinery
for
neutralization
of
free-radical
excess
and
be
used
variety
pathological
settings.
This
paper
aimed
to
provide
an
extensive
review
possible
uses
SODs
range
settings,
as
well
describe
current
pitfalls
delivery
strategies
development
solve
bioavailability
issues.
We
carried
out
PubMed
query,
using
keywords
“SOD”,
“SOD
mimetics”,
supplementation”,
which
included
papers
published
English
language,
between
2012
2020,
on
potential
therapeutic
applications
SODs,
including
detoxification
strategies.
As
highlighted
this
paper,
it
can
argued
generic
effects
beneficial
under
all
tested
conditions,
from
ocular
cardiovascular
diseases
neurodegenerative
disorders
metabolic
diseases,
diabetes
its
complications
obesity.
However,
must
underlined
clinical
evidence
efficacy
is
limited
consequently,
currently
far
being
demonstrated.
Bone Research,
Journal Year:
2022,
Volume and Issue:
10(1)
Published: March 9, 2022
Diabetic
osteoporosis
(DOP)
is
the
leading
complication
continuously
threatening
bone
health
of
patients
with
diabetes.
A
key
pathogenic
factor
in
DOP
loss
osteocyte
viability.
However,
mechanism
death
remains
unclear.
Here,
we
identified
ferroptosis,
which
iron-dependent
programmed
cell
death,
as
a
critical
murine
models
DOP.
The
diabetic
microenvironment
significantly
enhanced
ferroptosis
vitro,
shown
by
substantial
lipid
peroxidation,
iron
overload,
and
aberrant
activation
pathway.
RNA
sequencing
showed
that
heme
oxygenase-1
(HO-1)
expression
was
notably
upregulated
ferroptotic
osteocytes.
Further
findings
revealed
HO-1
essential
for
its
promoter
activity
controlled
interaction
between
upstream
NRF2
c-JUN
transcription
factors.
Targeting
or
efficiently
rescued
disrupting
vicious
cycle
peroxidation
activation,
eventually
ameliorating
trabecular
deterioration.
Our
study
provides
insight
into
pathogenesis,
our
results
provide
mechanism-based
strategy
clinical
treatment.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(3), P. 555 - 555
Published: March 15, 2022
The
heme
oxygenase
(HO)
enzyme
system
catabolizes
to
carbon
monoxide
(CO),
ferrous
iron,
and
biliverdin-IXα
(BV),
which
is
reduced
bilirubin-IXα
(BR)
by
biliverdin
reductase
(BVR).
HO
activity
represented
two
distinct
isozymes,
the
inducible
form,
HO-1,
a
constitutive
HO-2,
encoded
genes
(HMOX1,
HMOX2,
respectively).
HO-1
responds
transcriptional
activation
in
response
wide
variety
of
chemical
physical
stimuli,
including
its
natural
substrate
heme,
oxidants,
phytochemical
antioxidants.
expression
regulated
NF-E2-related
factor-2
counter-regulated
Bach-1,
heme-sensitive
manner.
Additionally,
HMOX1
promoter
polymorphisms
have
been
associated
with
human
disease.
induction
can
confer
protection
inflammatory
conditions
through
removal
pro-oxidant
potential
catalyst
lipid
peroxidation,
whereas
iron
released
from
may
trigger
ferritin
synthesis
or
ferroptosis.
production
heme-derived
reaction
products
(i.e.,
BV,
BR)
contribute
HO-dependent
cytoprotection
via
antioxidant
immunomodulatory
effects.
BVR
BR
newly
recognized
roles
regulation.
CO
alter
mitochondrial
function
leading
modulation
downstream
signaling
pathways
that
culminate
anti-apoptotic,
anti-inflammatory,
anti-proliferative
This
review
will
present
evidence
for
beneficial
effects
diseases,
cardiovascular
disease
(CVD),
metabolic
conditions,
diabetes
obesity,
as
well
acute
chronic
diseases
liver,
kidney,
lung.
Strategies
targeting
pathway,
genetic
expression,
application
BR,
gas,
donor
compounds
show
therapeutic
organ
ischemia/reperfusion
injury.
Evidence
studies
indicate
represent
biomarker
oxidative
stress
various
clinical
while
increases
serum
levels
correlated
inversely
risk
CVD
Ongoing
trials
investigate